1. Home
  2. FPF vs MRVI Comparison

FPF vs MRVI Comparison

Compare FPF & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$17.79

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.71

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPF
MRVI
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
FPF
MRVI
Price
$17.79
$5.71
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
96.0K
2.2M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
8.08%
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
N/A
$12.54
Revenue Next Year
N/A
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.21
$2.29
52 Week High
$19.75
$7.44

Technical Indicators

Market Signals
Indicator
FPF
MRVI
Relative Strength Index (RSI) 49.84 35.01
Support Level $17.56 $5.54
Resistance Level $18.24 $6.55
Average True Range (ATR) 0.16 0.34
MACD 0.03 -0.15
Stochastic Oscillator 60.43 20.81

Price Performance

Historical Comparison
FPF
MRVI

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: